Dr. Reddy's Laboratories Ltd Stock 12‑Month Price Target Raised to $13.41, Implies 1% Upside

Analysts covering Dr. Reddy's Laboratories Ltd raised the stock's average 12‑month price target to $13.41, up from $13.11, based on estimates from 38 analysts. The new target suggests about a 1% upside from the Oct. 23 close. The consensus rating remains Hold, with 40 analysts: 18 Buys, 11 Holds, 11 Sells.

Source: Dr. Reddy's Laboratories Ltd Stock 12‑Month Price Target Raised to $13.41, Implies 1% Upside — TradingView

A daily AI-made news meme from Jester · Oct 26, 2026.